BioSpace News Archive

CannaCraft, Inc., a large-scale cannabis manufacturer, announced today the appointment of Jim Hourigan as Chief Executive Officer, effective immediately

Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, today announced that Dirk Allison, President and Chief Executive Officer, and Brian Poff, Executive Vice President and Chief Financial Officer, will participate in the Stephens Nashville Investment Conference, which takes place November 13 - 15, 2019, in Nashville, Tennessee

Surgical Notes, a nationwide provider of revenue cycle services and solutions for the ambulatory surgery center (ASC) and surgical hospital markets, announces it has entered into a partnership with Simple Admit, a provider of automated patient relationship management for surgery centers.

Sun Nuclear has announced the release of the Daily QA™-MR, the world’s first daily array for MR-Guided Radiation Therapy (MRgRT).

Natural Alternatives International, Inc. (“NAI”) (Nasdaq: NAII), the company behind SR CarnoSyn®, a patented, sustained-release version of CarnoSyn® beta-alanine, is showcasing several new ingredient solutions for healthy aging at the Age Management Medicine Group (AMMG) Conference in Tucson, AZ on November 7-10, 2019 at JW Marriott Tucson Starr Pass Resort & Spa.

Avantor, Inc. (NYSE: AVTR) and the National Institute of Bioprocessing Research and Training (NIBRT) today announced they are teaming up to address downstream bottlenecks in buffer preparation when producing monoclonal antibodies (mAbs)

Antengene Corporation today announced that it has entered into a licensing agreement with AstraZeneca (LSE/STO/NYSE: AZN) under which Antengene has been granted the exclusive global rights to further develop and commercialize AZD0364

Mednet, a provider of eClinical solutions for the global life sciences community and Bioforum, a global, data-focused contract research organization (CRO), announced a partnership designed to enhance the efficiency of clinical studies and increase their flexibility

Ryvu Therapeutics (WSE: RVU), a clinical-stage biopharmaceutical company developing novel small molecule therapies that address emerging targets in oncology, today announced that two abstracts have been accepted for presentation at the 61st American Society of Hematology (ASH) Annual Meeting in Orlando, FL, taking place from December 7-10, 2019.

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that new data for its approved and investigational medicines across a range of blood diseases will be presented at the 61st American Society of Hematology (ASH) Annual Meeting from December 7–10 in Orlando, Florida.